Get in Touch
Contact Us
National team
Find Your Local Sales Agronomist

Maverick GII

long rotation ryegrass

  • Robust and densely tillered with exceptional cool season growth
  • Excellent summer quality (low aftermath heading)
  • Very good disease resistance
  • Perfect for oversowing
  • High yielding Italian perennial cross
  • Sowing rate dependent on environment and situation
Suitable For

Sowing Rate: 10-30kg/ha
Rainfall: Minimum 600mm per annum
Grazing Management Method: Rotational Grazed – Medium Term
Heading Date: Mid - 17+
Pasture Life: 6 mths - 2years
Soil Fertility: High (Olsen P 20+)
Ploidy: Diploid

Add hybrid vigour to your Italian ryegrass system

Maverick GII is a diploid short rotation ryegrass that offers improved growing performance over standard short term ryegrasses. This style of grass is best suited to situations where high winter production is required along with late season growth and quality.

Pasture seed sowing rate (sole): 20-30kg/ha
Pasture seed sowing rate (mixed): 10-20kg/ha

 

Sowing and Establishment

Maverick GII short rotation ryegrass can be sown at 15-25 kg/ha as a pure sward with Superstrike® treated clover, or added to a perennial pasture mix at 4-7 kg/ha. In an undersowing situation, sow Superstrike® treated seed at 10-15 kg/ha. 

For pasture seed sowing rates specific to your farming needs, contact your local DLF Seeds Sales Agronomist here

Grazing Management

Maverick GII short rotation ryegrass is best suited to rotational grazing. For best persistence, avoid hard grazing over summer.

Rainfall

Minimum 600mm rainfall per annum unless irrigated

2024 Product Guide
DLF Seeds 2024 Product Guide - Features product information, our latest innovations, trial data, management advice and more.
Northern Spring Guide 2023
DLF Seeds 2023 Tropical, Subtropical & Temperate Spring Guide - Features product information, our latest innovations, trial data, management advice and more.
Temperate Spring Guide 2023
DLF Seeds 2023 Temperate Spring Guide - Features product information, our latest innovations, trial data, management advice and more.